Current State of Combined Heart-Liver Transplantation in the United States

Journal of Heart and Lung Transplantation

Volumn 27, Issue 7, 2008, Pages 753-759

  Te, Helen S ^a   Anderson, Allen S ^a   Millis, J Michael ^a   Jeevanandam, Valluvan ^a   Jensen, Donald M ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ADULT; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; FOLLOW UP; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; LIVER DISEASE; LIVER GRAFT; LIVER TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL; UNITED STATES;

ADULT; AGED; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; UNITED STATES;

EID: 45449090807     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.04.004     Document Type: Article

References (41)

1. Befeler A.S., Schiano T.D., Lissoos T.W., et al. Successful combined liver-heart transplantation in adults: report of three patients and review of the literature. Transplantation 68 (1999) 1423-1427
2. Starzl T.E., Bilheimer D.W., Bahnson H.T., et al. Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet i (1984) 1382-1383
3. Porrett P.M., Desai S.S., Timmins K.J., et al. Combined orthotopic heart and liver transplantation: the need for exception status listing. Liver Transplant 10 (2004) 1539-1544
4. Cohen A.S. Amyloidosis. N Engl J Med 277 (1967) 522-530
5. Gillmore J.D., Lovat L.B., and Hawkins P.N. Amyloidosis and the liver. J Hepatol 30 suppl 1 (1999) 17-33
6. Shah K.B., Inoue Y., and Mehra M.R. Amyloidosis and the heart: a comprehensive review. Arch Intern Med 166 (2006) 1805-1813
7. Benson M.D., Yazaki M., and Magy N. Laboratory assessment of transthyretin amyloidosis. Clin Chem Lab Med 40 (2002) 1262-1265
8. Holmgren G., Ericzon B.G., Groth C.G., et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341 (1993) 1113-1116
9. Rydh A., Suhr O., Hietala S.O., et al. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med 25 (1998) 709-713
10. Suhr O.B., Herlenius G., Friman S., and Ericzon B.G. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transplant 6 (2000) 263-276
11. Stangou A.J., Hawkins P.N., Heaton N.D., et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 66 (1998) 229-233
12. Yazaki M., Tokuda T., Nakamura A., et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 274 (2000) 702-706
13. Grazi G.L., Cescon M., Salvi F., et al. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view. Liver Transplant 9 (2003) 986-992
14. Olynyk J.K., Cullen D.J., Aquilia S., et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341 (1999) 718-724
15. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
16. Alexander J., and Kowdley K.V. Hereditary hemochromatosis: genetics, pathogenesis, and clinical management. Ann Hepatol 4 (2005) 240-247
17. Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med 57 (2006) 331-347
18. Adams P.C., Deugnier Y., Moirand R., and Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 25 (1997) 162-166
19. Crawford D.H., Jazwinska E.C., Cullen L.M., and Powell L.W. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 114 (1998) 1003-1008
20. Sallie R.W., Reed W.D., and Shilkin K.B. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 32 (1991) 207-210
21. Bacon B.R., Olynyk J.K., Brunt E.M., Britton R.S., and Wolff R.K. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 130 (1999) 953-962
22. Guyader D., Jacquelinet C., Moirand R., et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 115 (1998) 929-936
23. Niederau C., Fischer R., Purschel A., et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110 (1996) 1107-1119
24. Farrell F.J., Nguyen M., Woodley S., et al. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 20 (1994) 404-410
25. Kowdley K.V., Hassanein T., Kaur S., et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transplant Surg 1 (1995) 237-241
26. Yu L., and Ioannou G.N. Survival of liver transplant recipients with hemochromatosis in the United States. Gastroenterology 133 (2007) 489-495
27. Alkofer B.J., Chiche L., Khayat A., et al. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant Proc 37 (2005) 2250-2252
28. Rela M., Muiesan P., Heaton N.D., et al. Orthotopic liver transplantation for hepatic-based metabolic disorders. Transplant Int 8 (1995) 41-44
29. Bahnson H.T., and Gordon R.D. Transplantation of other organs with the heart. Cardiovasc Clin 20 (1990) 237-248
30. Barbir M., Khaghani A., Kehely A., et al. Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia. Q J Med 85 (1992) 807-812
31. Offstad J., Schrumpf E., Geiran O., Soreide O., and Simonsen S. Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia. Clin Transplant 15 (2001) 432-436
32. Revell S.P., Noble-Jamieson G., Johnston P., et al. Liver transplantation for homozygous familial hypercholesterolaemia. Arch Dis Child 73 (1995) 456-458
33. Valdivielso P., Escolar J.L., Cuervas-Mons V., et al. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Ann Intern Med 108 (1988) 204-206
34. Detry O., Honore P., Meurisse M., et al. Advantages of inferior vena caval flow preservation in combined transplantation of the liver and heart. Transplant Int 10 (1997) 150-151
35. Olivieri N.F., Liu P.P., Sher G.D., et al. Combined liver and heart transplantation for end-stage iron-induced organ failure in an adult with homozygous beta-thalassemia. N Engl J Med 330 (1994) 1125-1127
36. Calne R.Y. Immunological tolerance-the liver effect. Immunol Rev 174 (2000) 280-282
37. Jiang M., and Han D. Auxiliary liver-heart transplantation in the rat: a new microsurgical model inducing tolerance. Transplant Proc 36 (2004) 1607-1609
38. Pinderski L.J., Kirklin J.K., McGiffin D., et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?. J Heart Lung Transplant 24 (2005) 1828-1833
39. Creput C., Durrbach A., Samuel D., et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 3 (2003) 348-356
40. Olausson M., Mjornstedt L., Norden G., et al. Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 7 (2007) 130-136
41. Gutierrez A., Crespo M., Mila J., et al. Outcome of simultaneous liver-kidney transplantation in highly sensitized, crossmatch-positive patients. Transplant Proc 35 (2003) 1861-1862